TEL AVIV, Israel--(BUSINESS WIRE)--CartiHeal (2009) Ltd., a privately held medical device developer of an innovative, cell-free cartilage regeneration technology, announced that it received an additional $5 million funding in cash from its existing investors: Elron, Accelmed and Access Medical Ventures. The continued investment is testament to the investors growing satisfaction in the company’s progress. The proceeds will be used to expand ongoing post-marketing clinical studies of Cartiheal’s signature product Agili-C™ in Europe.
Help employers find you! Check out all the jobs and post your resume.
